KESTER CAPITAL

Kester Capital is a leading UK mid-market private equity firm. It was established in 2007 as Greenhill Capital Partners Europe (“GCP Europe”), the European private equity arm of Greenhill & Co Inc. Kester Capital is managed by a team of experienced professionals and invests on behalf of a number of blue chip institutional investors. Kester Capital is currently investing its second fund, which was raised in 2013. Kester Capital's target equity investment size is £5 – 25 million.
KESTER CAPITAL
Industry:
Finance Financial Services Venture Capital
Founded:
2007-01-01
Status:
Active
Contact:
+44 (0)20 3747 5700
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Analytics Apple Mobile Web Clips Icon Google Universal Analytics Apache Google Maps COVID-19 Pound Sterling CPanel SSL
Similar Organizations
Arcadia Capital
Arcadia Capital is a mid-market private equity firm.
Capital A Investment Partners
Capital A Investment Partners is a mid market private equity firm.
CapVest Associates
CapVest is a European mid-market private equity firm.
Color Capital
Color Capital invests in things people buy, and how they buy them.
Gresham
Gresham is a leading independent UK mid-market private equity specialist.
Current Employees Featured
Founder
Acquisitions List
Date | Company | Article | Price |
---|---|---|---|
2021-10-13 | Rephine | Rephine acquired by Kester Capital | N/A |
2019-10-23 | You Garden | You Garden acquired by Kester Capital | N/A |
2019-08-05 | ComplianceOnline | ComplianceOnline acquired by Kester Capital | N/A |
2018-05-30 | Jollyes Retail Group | Jollyes Retail Group acquired by Kester Capital | N/A |
2017-09-29 | CETA Insurance | CETA Insurance acquired by Kester Capital | N/A |
2012-03-27 | Garrets International | Garrets International acquired by Kester Capital | 17 M GBP |
2012-01-01 | AgriBriefing | AgriBriefing acquired by Kester Capital | N/A |
2010-01-01 | Chiltern International | Chiltern International acquired by Kester Capital | N/A |
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2022-06-21 | Optibrium | Kester Capital investment in Private Equity Round - Optibrium | N/A |
2021-02-08 | Optibrium | Kester Capital investment in Private Equity Round - Optibrium | N/A |
2016-06-01 | Avania | Kester Capital investment in Private Equity Round - Avania | N/A |
2013-12-10 | Frontier Medical Group | Kester Capital investment in Private Equity Round - Frontier Medical Group | N/A |
2011-01-01 | Industry Dynamics | Kester Capital investment in Private Equity Round - Industry Dynamics | N/A |
2010-01-01 | Chiltern International | Kester Capital investment in Private Equity Round - Chiltern International | N/A |
2008-01-01 | Travel Entertainment Group, Ltd. | Kester Capital investment in Private Equity Round - Travel Entertainment Group, Ltd. | N/A |
2007-09-01 | Ironshore Insurance | Kester Capital investment in Private Equity Round - Ironshore Insurance | N/A |
2006-12-01 | Xanthus Pharmaceuticals | Kester Capital investment in Series B - Xanthus Pharmaceuticals | 25 M USD |
More informations about "Kester Capital"
Kester Capital
Kester Capital is a London-based firm providing first-time institutional capital to ambitious UK SMEs in healthcare, information and data, and technology sectors.See details»
Kester Capital - Crunchbase Investor Profile
Kester Capital is a leading UK mid-market private equity firm. It was established in 2007 as Greenhill Capital Partners Europe (“GCP Europe”), the European private equity arm of Greenhill & Co Inc. Kester Capital is managed by a team …See details»
Dentons advises Astorg on its acquisition of a majority stake in …
Jul 5, 2022 London—Dentons has advised Astorg, a leading private equity group, on its acquisition of a majority stake in Avania from Kester Capital.Kester Capital retains a minority …See details»
Kester Capital - LinkedIn
Kester Capital Investment Management London, England 3,101 followers Kester Capital is a primary buy-out specialist focused on backing ambitious UK businesses with potential for growth.See details»
Kester Capital - Investments, Portfolio & Company Exits
Jun 21, 2022 Kester Capital 's most notable exits include VIXIO Regulatory Intelligence, Chiltern International, ... a contract research organization, provides clinical development, scientific …See details»
Kester Capital investment portfolio - PitchBook
Kester Capital General Information Company Description. Founded in 2006, Kester Capital is a private equity investment firm based in London, United Kingdom. The firm seeks to invest in companies operating in the healthcare, …See details»
Legal - Kester Capital
The information and services provided on this website are not provided to and may not be used by any person or entity in any jurisdiction where the provision or use thereof would be contrary to …See details»
All news - Kester Capital
Kester Capital portfolio company, Factory-CRO Group, a leading global contract research organization (CRO) focused on medical devices and in vitro diagnostics (IVDs), and Boston …See details»
Kester Capital - Private Equity Investments & Executives
See Kester Capital's 16 investments, 10 executives, and complete investor profile. Founded in 2007, Kester Capital (formerly GCP Capital Partners) is a primary buy-out specialist focused …See details»
Bionical Emas sells EMAS Pharma to Kester Capital …
I’d like to thank everyone at Bionical Emas, EMAS Pharma and Kester Capital for making this happen and I look forward to a very successful 2025.” For further information on Bionical Emas, please contact: Vicky Keen …See details»
Kester Capital | Institution Profile | Private Equity International
Kester Capital. News, insights, analysis and data. Kester Capital overview. Founded in 2012, Kester Capital is a London-based investment firm that targets buyout investments across the …See details»
Kester Capital II: Fund Performance - PitchBook
Aug 11, 2020 Kester Capital II is a buyout fund managed by Kester Capital. The fund is located in London, United Kingdom and invests in United Kingdom. The fund targets healthcare, …See details»
Evestia Clinical: A Bold New Identity for EMAS Pharma in Oncology ...
The partnership with Kester Capital is crucial as Adam Maidment, a Managing Partner at Kester, remarked on the strategic importance of Evestia Clinical in a fast-growing global market. With …See details»
Kester Capital backs experienced management team in acquiring …
Dec 9, 2024 Kester Capital is a leading UK-headquartered lower mid-market private equity investor. Kester focuses on the life sciences and technology sectors, supporting businesses …See details»
Kester Capital III: Fund Performance - PitchBook
Mar 19, 2024 Kester Capital III is a 2023 vintage buyout fund managed by Kester Capital. The fund is located in London, United Kingdom, and invests in Western Europe. The fund targets …See details»
Kester Capital backs experienced management team in
Sep 12, 2024 Adam Maidment, Managing Partner at Kester Capital, commented: “Kester has invested in CROs for over a decade, and we believe EMAS Pharma is an excellent platform …See details»
KESTER CAPITAL III FP LP - Companies House
More for KESTER CAPITAL III FP LP (SL036173) Registered office address 50 Lothian Road, Festival Square, Edinburgh, EH3 9WJ . Company status Active Company type Limited …See details»
MEMBER NEWS - Re-flow secures investment from Kester Capital …
Following previous investment rounds and year on year rapid growth, this investment marks a major milestone, as Re-flow transitions towards international expansion. Kester’s deep sector …See details»
KESTER CAPITAL III FP GP LLP overview - Find and update …
Jan 18, 2023 More for KESTER CAPITAL III FP GP LLP (SO307703) Registered office address 50 Lothian Road, Festival Square, Edinburgh, Scotland, EH3 9WJ . Company status Active …See details»
Eric Trump announces lawsuit against Capital One over alleged de ...
Mar 7, 2025 The Trump Organization is suing Capital One for de-banking its accounts in 2021, according to Eric Trump. The lawsuit was filed in Miami-Dade Circuit Court and claimed that …See details»